The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
:)
Date Time Trade Prc Volume Buy/Sell Bid Ask Value
15-Mar-21 17:41:23 0.354 100,000,000 Buy* 0.35 0.355 354.00k O
15-Mar-21 17:41:23 0.345 100,000,000 Sell* 0.35 0.355 345.00k O
This, say experts, not only makes a violent rebound of the disease likely but makes predicting which strain will hit us next and - crucially - deciding which vaccine to produce much more difficult.
Decision makers are also concerned that the current pressure on the flu virus could also see a more transmissible stain emerge.
Dr John McCauley, director of the Worldwide Influenza Centre at the Francis Crick Institute - one of five WHO collaborating centres that constantly track pandemic flu viruses and helps to update influenza vaccines - said the current situation is unprecedented.
“I don’t think we’ve been in a position with so little flu in circulation for over a century,” he said. “What that means is overall in the population there’s less experience and therefore there’s less boosting of immunity.”
Dr McCauley added that identifying which strains this year’s vaccine must protect against has proved tricky, as the number of samples taken from flu strains has fallen 20 fold globally. “Because we’re looking at fewer samples, we don’t really know how representative they are,” he said.
Date Time Trade Prc Volume Buy/Sell Bid Ask Value
17-Feb-21 17:16:51 0.27 100,000,000 Unknown* 0.29 0.30 270.00k O
17-Feb-21 14:35:15 0.28 17,000,000 Unknown* 0.29 0.30 47.60k O
17-Feb-21 13:32:00 0.281 25,000,000 Unknown* 0.29 0.30 70.25k O
17-Feb-21 17:14:56 0.295 59,693,476 Unknown* 0.29 0.30 176.10k O
SNG Late Trades at 18:09
Date Time Trade Prc Volume Buy/Sell Bid Ask Value
16-Feb-21 17:48:39 189.397 4,950 Unknown* 188.00 189.00 9,375 O
16-Feb-21 17:41:01 188.501 1,394 Unknown* 188.00 189.00 2,628 O
16-Feb-21 15:34:38 185.803 10,000 Unknown* 188.00 189.00 18.58k O
16-Feb-21 15:33:50 186.744 9,277 Unknown* 188.00 189.00 17.32k O
16-Feb-21 15:32:13 185.65 10,000 Unknown* 188.00 189.00 18.57k O
16-Feb-21 16:27:30 188.02 5,603 Unknown* 188.00 189.00 10.53k O
16-Feb-21 16:22:17 187.02 6,244 Unknown* 188.00 189.00 11.68k O
16-Feb-21 17:16:59 188.995 567 Unknown* 188.00 189.00 1,072 O
16-Feb-21 17:16:50 189.00 34,868 Unknown* 188.00 189.00 65.90k O
16-Feb-21 16:16:23 188.00 5,360 Unknown* 188.00 189.00 10.08k O
15-Feb-21 08:14:53 195.982 17,000 Unknown* 188.00 189.00 33.32k O
15-Feb-21 08:59:18 189.00 18,384 Unknown* 188.00 189.00 34.75k O
15-Feb-21 11:48:52 191.44 13,056 Unknown* 188.00 189.00 24.99k O
15-Feb-21 15:54:52 191.499 19,203 Unknown* 188.00 189.00 36.77k O
15-Feb-21 08:25:37 193.00 25,906 Unknown* 188.00 189.00 50.00k O
15-Feb-21 16:28:40 192.01 15,111 Unknown* 188.00 189.00 29.01k O
15-Feb-21 10:22:00 191.00 20,000 Unknown* 188.00 189.00 38.20k O
15-Feb-21 08:35:36 190.738 30,000 Unknown* 188.00 189.00 57.22k O
15-Feb-21 12:57:52 193.00 15,000 Unknown* 188.00 189.00 28.95k O
15-Feb-21 12:50:16 194.127 11,166 Unknown* 188.00 189.00 21.68k O
15-Feb-21 08:24:43 192.664 14,090 Unknown* 188.00 189.00 27.15k O
15-Feb-21 08:35:47 190.886 210,000 Unknown* 188.00 189.00 400.86k O
15-Feb-21 13:14:35 193.00 15,000 Unknown* 188.00 189.00 28.95k O
15-Feb-21 09:23:47 191.441 30,365 Unknown* 188.00 189.00 58.13k O
15-Feb-21 08:02:44 189.649 20,000 Unknown* 188.00 189.00 37.93k O
15-Feb-21 08:01:27 193.048 24,000 Unknown* 188.00 189.00 46.33k O
15-Feb-21 08:04:22 192.117 20,000 Unknown* 188.00 189.00 38.42k O
15-Feb-21 10:18:23 193.444 12,000 Unknown* 188.00 189.00 23.21k O
15-Feb-21 09:35:07 191.215 70,000 Unknown* 188.00 189.00 133.85k O
15-Feb-21 08:10:01 197.00 25,380 Unknown* 188.00 189.00 50.00k O
15-Feb-21 09:00:50 186.743 21,426 Unknown* 188.00 189.00 40.01k O
15-Feb-21 08:36:17 190.405 30,000 Unknown* 188.00 189.00 57.12k O
15-Feb-21 08:05:29 194.37 14,100 Unknown* 188.00 189.00 27.41k O
15-Feb-21 08:34:58 190.00 20,000 Unknown* 188.00 189.00 38.00k O
15-Feb-21 09:28:17 194.86 15,003 Unknown* 188.00 189.00 29.23k O
15-Feb-21 16:27:36 192.792 14,444 Unknown* 188.00 189.00 27.85k O
15-Feb-21 10:20:25 191.77 15,000 Unknown* 188.00 189.00 28.77k O
15-Feb-21 08:32:09 190.670 15,000 Unknown* 188.00 189.00 28.60k O
15-Feb-21 09:17:05 191.00 32,000 Unknown* 188.00 189.00 61.12k O
15-Feb-21 08:59:45 188.428 14,100 Unknown* 188.00 189.00 26.57k O
15-Feb-21 08:29:47 190.917 24,000 Unknown* 188.00 189.00 45.82k O
15-Feb-21 09:16:29 190.750 36,379 Unknown* 188.00 189.00 69.39k O
15-Feb-21 14:17:00 192.644 12,977 Unknown* 188.00 189.00 25.00k O
15-Feb-21 08:07:08
Date Time Trade Prc Volume Buy/Sell Bid Ask Value
09-Feb-21 16:15:57 174.254 13,202 Unknown* 174.00 175.00 23.01k O
09-Feb-21 08:01:56 174.897 19,190 Unknown* 174.00 175.00 33.56k O
09-Feb-21 15:55:09 173.25 19,231 Unknown* 174.00 175.00 33.32k O
09-Feb-21 09:25:11 175.853 22,742 Unknown* 174.00 175.00 39.99k O
09-Feb-21 10:13:29 175.28 17,510 Unknown* 174.00 175.00 30.69k O
09-Feb-21 12:04:27 174.00 13,000 Unknown* 174.00 175.00 22.62k O
09-Feb-21 08:02:28 173.810 16,444 Unknown* 174.00 175.00 28.58k O
09-Feb-21 14:59:34 176.669 20,000 Unknown* 174.00 175.00 35.33k O
09-Feb-21 09:25:29 175.40 15,389 Unknown* 174.00 175.00 26.99k O
09-Feb-21 14:30:57 176.50 30,000 Unknown* 174.00 175.00 52.95k O
09-Feb-21 12:40:09 178.806 100,000 Unknown* 174.00 175.00 178.81k O
09-Feb-21 16:08:36 173.50 19,000 Unknown* 174.00 175.00 32.97k O
09-Feb-21 14:30:44 175.00 30,000 Unknown* 174.00 175.00 52.50k O
09-Feb-21 09:24:36 174.00 22,984 Unknown* 174.00 175.00 39.99k O
09-Feb-21 09:24:53 174.179 22,960 Unknown* 174.00 175.00 39.99k O
09-Feb-21 15:02:00 174.036 27,057 Unknown* 174.00 175.00 47.09k O
09-Feb-21 15:01:44 175.70 42,000 Unknown* 174.00 175.00 73.79k O
09-Feb-21 08:01:22 176.499 21,177 Unknown* 174.00 175.00 37.38k O
09-Feb-21 08:09:46 173.012 40,000 Unknown* 174.00 175.00 69.20k O
Hi Dibs, interesting because the url does end with Synairgen as below.
https://secure.phc.ox.ac.uk/sentry/national111/live/survey/open?id=screening&path=synairgen
Hi Folks,
Did anyone else receive an email this morning? Interestingly it was sent to my work email address. Details below.
Southampton, UK – 13 January 2021: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, today announces that the first patient has been dosed in the UK as part of its global Phase III trial (SG018) evaluating Synairgen’s inhaled formulation of interferon beta-1a (SNG001), for the treatment of hospitalised COVID-19 patients.
As previously announced, Synairgen has appointed Parexel Biotech, a division of the leading global clinical research organisation, Parexel, to help conduct the Phase III trial and several UK sites have now been initiated, with further sites in the US and the EU expected to follow. The trial is deemed an Urgent Public Health study by the UK’s National Institute for Health Research (NIHR). In the US, SNG001 has been granted Fast Track status from the US Food and Drug Administration (FDA). The Company is seeking further equivalent prioritisations and support from governments in participating countries.
Synairgen’s SG018 trial is a randomised placebo-controlled study being conducted in approximately 20 countries enrolling a total of 610 COVID-19 patients who require supplemental oxygen. After reporting the results for the primary and key secondary endpoints of the study, enrolled patients will continue to be assessed for long-COVID-19 symptoms.
Richard Marsden, CEO of Synairgen, commented: “We need treatments as well as vaccines to fight highly pathogenic viruses such as SARS-CoV-2. Development of treatments like ours will remain necessary in cases where vaccines are not effective, for those who do not get vaccinated, and in case the virus mutates to the point where vaccines become less effective. We believe this trial presents an opportunity for a significant UK scientific breakthrough and, if given the right support, our drug could rapidly assist with the global crisis.”
Synairgen is also running an ongoing Phase II trial of inhaled interferon beta in non-hospitalised ‘at risk’ patients, (SG016), that is progressing rapidly. For more information and to take part, visit www.covidtrialathome.com.
This announcement contains inside information as contained in Article 7 of the Market Abuse Regulation No. 596/2014 (‘MAR’).